The Zhitong Finance App learned that Chunyu Healthcare (00108) rose more than 5% in the afternoon, and the cumulative increase during the month had already exceeded 33%. As of press release, it rose 5.19% to HK$2.84, with a turnover of HK$3.410,400.

According to news, in September of this year, Dr. Chunyu, the core platform of Chunyu Medical under Guorui Group, signed a strategic cooperation agreement with the international high-end medical brand Ritz-Carle Group. This cooperation is an important business practice for Dr. Chunyu to open up a closed loop of health management throughout the user life cycle. It is also a key step for Guorui Group to promote the deep integration of “digital healthcare+high-end health+high-end community scenarios”.

According to public information, in December of last year, Guorui Life, a Hong Kong stock listed company under Guorui Group, acquired 78.3% of Dr. Chunyu's shares for 269 million yuan. In July of this year, after completing the acquisition, Guorui Life officially changed its name to “Chunyu Medical”. With the official launch of “Chunyu Medical Technology”, Guorui Group will collaborate deeply with its industrial technology sector and asset management sector to extend Dr. Chunyu's digital medical service capabilities to a wider range of properties, communities and cities.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.